1. Amniotic fluid is produced by the fetus urinating and respiratory secretions into the amniotic sac. It allows room for fetal growth and protects the fetus from trauma. 2. Abnormalities in amniotic fluid volume include oligohydramnios (low volume) and polyhydramnios (high volume). Oligohydramnios can cause fetal deformities and pulmonary hypoplasia while polyhydramnios increases risks of preterm labor and fetal malpresentation. 3. Causes of the abnormalities include fetal anomalies, maternal diabetes, and premature rupture of membranes. Management involves monitoring for complications, treating any underlying causes, and possibly inducing labor if fetal lung

1. AMNIOTIC FLUID
Fahad zakwan

3. Amniotic fluid formation and composition:
First & early second trimester:
• Amount is 5-50 ml & arises from:
• ultrafiltrate of Maternal plasma through the vascularized
uterine decidua (in early pregnancy).
• Transudation of fetal plasma through the fetal skin &
umbilical cord (up to 20 weeks' gestation).
* It is iso-osmolar with fetal & maternal plasma,
though it is devoid of proteins.

4. Volume and composition
• From 20 weeks up to term (mainly fetal urine):
• At 18th week, the fetus voids 7-14ml/day; at term fetal kidneys secretes 600-
700ml of urine/day into AF.
• Fetal respiratory tract secretes 250ml/day into AF.
• Fluid transfers across the placenta.
• Fetal oro-nasal secretions.
• Secretion is controlled by:
- Fetal swallowing at term removes 500ml/day.
- Reabsorption into maternal plasma (osmotic gradient).
• AF constituents:
- urea, creatinine & uric acid + desquamated fetal cells, vernix, lanugo hair &
others→ hypo-osmolar amniotic fluid….

5. Amniotic fluid circulation

7. Amniotic fluid volume :
• About 500mls enter and leave the amniotic sac each hour.
• gradual ↑ up to 36 weeks to around 600 to 1000 ml
then↓ after that.
• The normal range is wide but the approximate volumes
are:
- 500 ml at 18 weeks
- 800 ml at 34 weeks.
- 600 ml at term.

8. Amniotic fluid function:
1. Allow room for fetal growth, movement and development.
2. Ingestion into GIT→ growth and maturation.
3. Fetal pulmonary development (20 weeks).
4. Protects the fetus from trauma.
5. Maintains temperature.
6. Contains antibacterial activity.
7. Aids dilatation of the cervix during labour.

9. Clinical importance of AF:
1. Screening for fetal malformation (serum α-
fetoprotien).
2. Assessment of fetal well-being (amniotic fluid
index).
3. Assessment of fetal lung maturity (L/S ratio).
4. Diagnosis and follow up of labour.
5. Diagnosis of PROM (ferning test).

10. Amniotic fluid volume assessment
•Clinical assessment is unreliable.
•Objective assessment depends on U/S to
measure:
- deepest vertical pool (DVP).
- Amniotic fluid index (AFI).
•It is a total of the DVPs in each four quadrants of
the uterus. it is a more sensitive indicator of AFV
throughout pregnancy.

11. Amniotic fluid abnormalities
Oligohydramnios:
Defined as reduced amniotic fluid of 200ml or less i.e.
amniotic fluid index of 5 cm or less or the deepest
vertical pool < 2 cm.
Polyhydramnios:
Defined as excessive amount of amniotic fluid of
2000ml or more (AFI of > 25 cm or the deepest
vertical pool of > 8 cm) .

12. POLYHYDROMNIOUS

13. Polyhydramnios

14. types
1. Mild hydramnios (80%):
a pocket of amniotic fluid measuring 8 to 11 cm.
2. moderate hydramnios (15%):
a pocket of amniotic fluid measuring 12 to 15 cm.
3. Severe hydramnios (5%) - twin-twin transfusion
syndrome :
a pocket of amniotic fluid measuring 16 cm or more.

16. ETIOLOGY OF POLYHYDRAMNIOS
1. Idiopathic
2. Fetal Anomalies
3. Diabetes
4. Multifetal gestation
5. Immune/Non-immune hydrops
6. Fetal infection
7. Placental haemangiomas

17. Fetal Anomalies
•Problems with swallowing and GI absorption
•Increased transudation of fluid:
•anencephaly, spina bifida
•Increased urination: anencephaly (lack of ADH,
stimulation of urination centers)
•Decreased inspiration

18. SYMPTOMS
1. Dyspnea
2. Abdominal pain
3. Venous stasis
4. Contractions  preterm labor
5. Decreased Perception of Fetal
Movements

19. diagnosis of polyhydramnios
•Symptoms:
- dyspnea.
- edema.
- abdominal distention
- preterm labour.
• Abdominal examination:
- ↑uterus than expected.
- difficult to palpate fetal parts.
- difficult to hear fetal heart
sound.
- ballotable fetus.
- Decreased fetal mov’t
•Ultrasound:
- excessive amniotic
fluid.
- fetal abnormalities.

20. COMPLICATIONS
(fetus)?
• Fetal prognosis worsens with more severe
hydramnios and congenital anomalies
• 15-20% fetal malformations
• Preterm delivery
• Suspect diabetes
• Prolapse of cord
• Abruption

21. (Mother)?
• Dyspnea
• Venous Stasis
• Placental abruption
• Uterine atony
• PPH
• Abnormal presentation -- C/S

22. TREATMENT
•Mild to Moderate hydramnios: rarely requires
treatment
•Hospitalization, bed rest
•Amniocentesis
•NSAIDs
•Blood sugar control

24. OLIGOHYDRAMNIOS

25. DEFINITION
reduced amniotic
fluid <200mls i.e.
amniotic fluid index
of 5 cm or less or
the deepest vertical
pool < 2 cm.

26. AETIOLOGY
FETAL
• PROM (50%)
• CHROMOSOMAL ANOMALIES
• CONGENITAL ANOMALIES
• IUGR
• IUFD
• POSTTERM PREGNANCY
MATERNAL
• PREECLAMPSIA
• APLA SYNDROME
• CHRONIC HT
PLACENTAL
• CHRONIC ABRUPTION
• TTTS
• CVS
DRUGS
• PG SYNTHETASE INHIBITORS
• ACE INHIBITORS
IDIOPATHIC

28. Complications of oligohydramnios:
In early pregnancy:
•Amniotic adhesions or bands→ amputation/death.
•Pressure deformities (club feet).
•Pulmonary hypoplasia:
- Thoracic compression.
- No breathing movement.
- No amniotic fluid retain.
 Flattened face.
 Postural deformities.

29. In late pregnancy:
•Fetal growth restriction.
•Placental abruption.
•Preterm labour.
•Fetal distress.
•Fetal death.
•Meconium aspiration.
•Labour induction/CS.

30. • Extremely poor fetal prognosis, especially in early
pregnancy
• Adhesions between amnion and fetal parts ---
malformations and amputations
• Musculoskeletal deformities
• Pulmonary hypoplasia
• Cord Compression -- >fetal hypoxia
• Passage of meconium into low AF volume: thick
particulate suspension -->respiratory compromise

31. management
• Minor degrees: no treatment.
• Bed rest, diuretics, water and salt restriction: ineffective.
• Hospitalization: dyspnea, abdominal pain or difficult ambulation.
• Endomethacin therapy: .
- impairs lung liquid production/enhances absorption.
- ↓fluid movement across fetal membranes.
* complications: premature closure of ductus arteriosus, impairment of renal
function, and cerebral vasoconstriction. So not used after 35 weeks
• Amniocentesis: to relieve maternal distress and to test for fetal lung maturity.
Complications: ruptured membrane, chorioamnionitis, placental abruption,
preterm labour.

32. Dr Mona Shroff
www.obgyntoday.info
32

33. TREATMENT
• ADEQUATE REST – decreases dehydration
• HYDRATION – Oral/IV Hypotonic fluids(2 Lit/d)
temporary increase
helpful during labour,
• SERIAL USG – Monitor growth, AFI, BPP
• INDUCTION OF LABOUR/ LSCS
Lung maturity attained
Lethal malformation
Fetal jeopardy
Severe IUGR
Severe oligohydramnios
• AMNIOINFUSION

34. • AMNIOINFUSION
INDICATIONS
1.Diagnostic
2.Prophylactic
3.Therapeutic
• Decreases cord compression
• Dilutes meconium